BLACK DIAMOND THERAPEUTICS
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small-molecule. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform namely, Mutation-Allostery-Pharmacology which is targeting mutations in cancer. Black Diamond focused on the discovery and development of precision medicines for cancer that is directed against a novel class of allosteric mutant oncogenes. The company targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist. It is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry.
BLACK DIAMOND THERAPEUTICS
Industry:
Biotechnology Life Science Medical
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.blackdiamondtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
617-417-5868
Total Funding:
197.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Organization Schema Office 365 Mail IPv6
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Current Advisors List
Board_member
2019-12-01
Current Employees Featured
David M. Epstein Founder, President & Chief Executive Officer @ Black Diamond Therapeutics
Founder, President & Chief Executive Officer
Alexander Mayweg Founding, Chief Scientific Officer @ Black Diamond Therapeutics
Founding, Chief Scientific Officer
Christopher Roberts Chief Scientific Officer @ Black Diamond Therapeutics
Chief Scientific Officer
Sergey Yurasov Chief Medical Officer @ Black Diamond Therapeutics
Chief Medical Officer
2022-06-01
Elizabeth Montgomery Chief People Officer @ Black Diamond Therapeutics
Chief People Officer
2022-02-01
Elizabeth Buck Founder, Executive Vice President @ Black Diamond Therapeutics
Founder, Executive Vice President
2015-01-01
Brent Hatzis-Schoch COO and General Counsel @ Black Diamond Therapeutics
COO and General Counsel
Founder
Stock Details
Investors List
Nextech Invest
Nextech Invest investment in Series C - Black Diamond Therapeutics
BVF Partners
BVF Partners investment in Series C - Black Diamond Therapeutics
Logos Capital
Logos Capital investment in Series C - Black Diamond Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - Black Diamond Therapeutics
Invus
Invus investment in Series C - Black Diamond Therapeutics
Wellington Management
Wellington Management investment in Series C - Black Diamond Therapeutics
Versant Ventures
Versant Ventures investment in Series C - Black Diamond Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series C - Black Diamond Therapeutics
Roche Venture Fund
Roche Venture Fund investment in Series C - Black Diamond Therapeutics
City Hill Ventures
City Hill Ventures investment in Series C - Black Diamond Therapeutics
Key Employee Changes
Official Site Inspections
http://www.blackdiamondtherapeutics.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.67 K
- Host name: cloudhost-10606077.us-midwest-2.nxcli.net
- IP address: 199.189.225.244
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Black Diamond Therapeutics"
Black Diamond Therapeutics - LinkedIn
Black Diamond Therapeutics is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations, expanding the addressable patient population by offering ...See details»
Investors & News - Black Diamond Therapeutics, Inc.
Nov 1, 2024 The Investor Relations website contains information about Black Diamond Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Black Diamond Therapeutics, Inc. (BDTX) - Yahoo Finance
See the company profile for Black Diamond Therapeutics, Inc. (BDTX) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Black Diamond Therapeutics Announces Pipeline Prioritization and ...
Apr 25, 2022 Black Diamond discovers and develops selective MasterKey therapies against these families of oncogenic mutations. Black Diamond was founded by David M. Epstein, …See details»
Press Release - investors.blackdiamondtherapeutics.com
Mar 19, 2025 The partnership underscores Servier’s commitment to developing targeted therapies that address unmet medical needs in oncology Servier will develop and …See details»
Black Diamond Therapeutics - Crunchbase
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small-molecule. It is engaged in discovering and developing small …See details»
Black Diamond Therapeutics, Inc. (BDTX) Company Profile
Jan 30, 2020 Company profile for Black Diamond Therapeutics, Inc. (BDTX) stock, with a description, list of executives, contact details and other key facts.See details»
Press Release - Black Diamond Therapeutics, Inc.
Jun 13, 2023 The Company’s proprietary MAP drug discovery engine is designed to allow Black Diamond to analyze population-level genetic sequencing tumor data and validate MasterKey …See details»
Who Owns Black Diamond Therapeutics
Dec 19, 2024 Ownership Structure of Black Diamond Therapeutics Black Diamond Therapeutics is a medical company that is dedicated to analyzing genetically defined cancers. As with any …See details»
Black Diamond Therapeutics, Inc. (Black Diamond Therapeutics, Inc ...
For more information, please visit www.blackdiamondtherapeutics.com. Forward-Looking Statements Statements contained in this press release regarding matters that are not historical …See details»
Servier and Black Diamond Therapeutics Announce Global …
Mar 19, 2025 Suresnes (France), Cambridge, Mass. (USA), March 19, 2025 – Servier, an independent global pharmaceutical group governed by a non-profit foundation, and Black …See details»
Black Diamond Therapeutics Company Profile - Craft
Oct 29, 2024 Black Diamond Therapeutics has 5 employees across 4 locations. See insights on Black Diamond Therapeutics including office locations, competitors, revenue, financials, …See details»
Black Diamond Therapeutics - 2025 Company Profile - Tracxn
5 days ago Black Diamond Therapeutics - Developer of small molecule based therapeutics for cancer treatment. Public Company. Raised a total funding of $182M over 3 rounds from 21 …See details»
Black Diamond Therapeutics - Work in biotech
Black Diamond Therapeutics is developing small molecule therapies to meet the unmet need for precision oncology. Cancer is a genetic disease of which many are caused by mutations in …See details»
Black Diamond Therapeutics - Company info. interviews, news
Black Diamond Therapeutics Inc. is a venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel …See details»
Black Diamond Therapeutics Company Overview, Contact Details ...
Jun 29, 2023 What is Black Diamond Therapeutics 's stock symbol? Black Diamond Therapeutics is a publicly traded company; the company's stock symbol is BDTX. What is …See details»
Black Diamond Therapeutics to Participate in Upcoming
Nov 1, 2024 Webcasts will be available at the start of the presentations on the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. Replays of the …See details»
Black Diamond Therapeutics Presents Preclinical Data on
Oct 8, 2021 Black Diamond was founded by David M. Epstein, Ph.D., and Elizabeth Buck, Ph.D. For more information, please visit www.blackdiamondtherapeutics.com. Forward-Looking …See details»
Black Diamond Therapeutics, Inc. - Cruelty Free Investing
Our Opinion Black Diamond Therapeutics, Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s …See details»
Servier and Black Diamond Therapeutics Announce Global
Mar 19, 2025 The partnership underscores Servier’s commitment to developing targeted therapies that address unmet medical needs in oncology Servier will develop and …See details»